Roig-Soriano, Joan http://orcid.org/0000-0002-6134-3141
Sánchez-de-Diego, Cristina http://orcid.org/0000-0002-0905-1213
Esandi-Jauregui, Jon http://orcid.org/0000-0001-5529-2686
Verdés, Sergi http://orcid.org/0000-0002-4266-5380
Abraham, Carmela R. http://orcid.org/0000-0002-6649-1960
Bosch, Assumpció http://orcid.org/0000-0002-7205-2796
Ventura, Francesc http://orcid.org/0000-0001-9673-9405
Chillón, Miguel http://orcid.org/0000-0003-0840-2111
Funding for this research was provided by:
Direcció General de Recerca, Generalitat de Catalunya (2018FI_B00657, 2020FI_SDUR0037, 2020FI_B100054)
Ministerio Ciencia Innovación, Retos Sociedad (PID2019-104034RB-I00)
Ministerio de Economía, Industria y Competitividad (PID2020-116735RB-I00)
Carlos III Institute of Health (RD21/0017/0008)
Article History
Received: 19 October 2022
Accepted: 7 March 2023
First Online: 14 March 2023
Competing interests
: Portions of this work are the subject of a patent application held by the Universitat Autonòma de Barcelona (UAB, Spain); the Universitat de Barcelona (UB, Spain); the Institucio Catalana de Recerca i Estudis Avançats (ICREA, Spain); and the Vall d'Hebron Institute of Research (VHIR, Spain). J.R., A.B., and M.C. are included in this patent application. C.R.A. is the co-founder of Klogenix, a company that is seeking to develop Klotho-boosting therapeutics. No other authors possess a conflict of interest.